NURS 453 test 1 Flashcards
COPD characterized by
airflow limitation, breathlessness, and exacerbation.
COPD disease process os based mainly off of what concept
inflammation
process of COPD
inhaling noxious particles which releases inflammatory mediators. this causes damage to the tissue of the lungs and an increase in mucus. The lungs become more and more injured which leads to structural remodeling and an increase in scar tissue. the result is either pulmonary fibrosis or damage/destruction (emphysema)
pulmonary fibrosis
thickening of the tissue between the alveoli
emphysema
damaged alveoli in which they trap air
characteristic of chronic bronchitis
chronic, productive cough for more than 3 months over consecutive 2 years. it is inflammation of bronchi r/t chronic exposure
emphysema
abnormal permanent enlargement of the air spaces which causes a loss of lung elasticity and causes difficulty with exhaling
Key preventative measure with COPD
smoking cessation to prevent and slo progression of disease
antitrypsin (AAT) deficiency
genetic risk factor for COPD. Deficiency of AAT causes a breakdown of elastin in alveoli, and inability to make coagulation factors in the liver.
antitrypsin (AAT)
protects and inhibits lysis of the lung tissue during inflammation.
elastin
gives elasticity and strength to the alveoli
goals for medication during COPD
reduce dyspnea, improve exercise tolerance, and prevent complications
with what assessment findings is COPD considered
intermittent cough (usually in AM) or with exertion, sputum production, dyspnea, exposure to risk factors,
COPD causes a high risk for
depression due to quality of life decrease
early clinical manifestations of COPD
dyspnea with exertion every day, air hunger, gasping, increase effort of breathing, chronic cough or sputum production, fatigue
physical assessment of COPD
barrel chest, underweight, increase expiratory phase, wheezes, decrease breath sounds, tripod position, purse lip breathing, LE edema, polycythemia, cyanosis
late clinical manifestations of COPD
clubbing and dyspnea at rest
what labs do you want for COPD
WBC and sputum cultures- PNA or infection
Hgb/Hct - may be increased due to chronic low level of O2
ABGs - hypoxic
electrolytes - Na/K, BUN, glucose
trops - if MI caused acute exacerbation
BNP - if HF caused acute exacerbation
D-dimer - if PE caused acute exacerbation
COPD diagnostics for acute exacerbation
CXR - to determine PNA
echocardiogram - determines cor pulmonale
12 lead ECG - if from an MI
spiral CT - if from PE
COPD diagnostics for chronic phase
pulmonary function test - determines COPD progression
echocardiogram - determines cor pulmonale
characteristics of acute exacerbation of COPD
change or worsening of COPD symptoms such as increase in dyspnea, cough, and sputum
what would put a acute exacerbation COPD pt Into the ICU
worsening hypoxemia, increasing hypercapnia, severe or worsening respiratory acidosis
what do you need to think about with labs and diagnostics in acute exacerbation of COPD
what the cause is (PNA, MI, PE?)
ABG findings in exacerbation
low PaO2 and SaO2
high PaCO2
normal or low PH
high HCO3
COPD meds for maintenance
anticholinergic agents (ipratropium)- long acting, steroid with LABA (Advair or Symbicort)
COPD meds for acute exacerbation
short acting beta 2 agonist (albuterol), antibiotic, steroid
bronchodilators
relaxes smooth muscles and improves lung ventilation
mucolytic agents
help thin secretions making them easier for the pt to expel
caution with beta blockers with COPD pts, why?
it can cause the bronchioles to constrict
types of breathing for COPD
pursed lip - prolongs exhalation
diaphragmatic breathing - achieves maximum inhalation and decreased RR
Patient care goals in COPD
conserve energy, reduce fatigue, facilitate removal of secretions
Patient care goals in COPD
conserve energy, reduce fatigue, facilitate removal of secretions
smoking cessation strategies
pharmacological support and one to one counseling
pharmacological support for smoking cessation
Nicotine supplements, bupropion (wellbutrin, zyban), varenicline (chantix)
pulmonary hypertension
Chronic progressive disease of small pulmonary arteries (PA) leading to increase pressure in the arteries and vascular remodeling. This can lead to backflow into the right ventricle which puts extra work on it and can lead to failure.
pulmonary hypertension classic symptoms
dyspnea on exertion and fatigue due to low cardiac output
is pulmonary hypertension curable
no
1 cause of pulmonary hypertension
COPD but there are a lot of reasons that can lead you to PH such as PE, HF, or medications
pulmonary hypertension labs
ABGs, CBC, electrolytes, BNP
diagnostic studies for pulmonary HTN
right cardiac Cath, 12 lead ECG, CT scan
right cardiac Cath
Examines the right atrium, right ventricle and pulmonary pressures through vena cava. should see a increase in pulmonary artery and vascular pressure
cor pulmonale
Enlargement of the right ventricle secondary to primary disorder or disease of the pulmonary system
most common cause of cor pulmonale
COPD. pulmonary HTN is usually a preexisting condition but not always
clinical manifestations of cor pulmonale
Symptoms are subtle and masked by symptoms of the pulmonary condition, but should see exertional dyspnea, tachypnea, cough, fatigue
Also: RV hypertrophy, increased intensity of S2, chronic hypoxemia
Right sided heart failure signs and symptoms
Peripheral Edema 3+ Weight Gain JVD Full, Bounding Pulse Enlarged Liver
care for cor pulmonale
treat underlying condition, O2, palliative care procedures
goal of Pharm management of PH and Cor Pulmonale
promote vasodilation of pulm vasculature, RV overload, & reverse remodeling
meds for PH and cor pulmonale
calcium channel blocker, vasodilators, endothelial receptor antagonist, viagra, oxygen, diuretics, anticoagulants, inotropic agents
endothelial receptor antagonist
Given PO; binds to endothelin-1 receptors:↓ PA pressures, ↑ cardiac output
for PH and cor pulmonale
DVT is a concept of
inflammation
PE Is a concept of
perfusion that causes an issue of oxygenation and ventilation
pulmonary thromboembolism
Obstruction of one or more of the pulmonary arteries or one of it’s branches by a thrombus (VTE/DVT)
if PE is not treated what can happen to the patient
the patent will go into shock due to right ventricular dysfunction (blood backing up into the ventricle and not able to keep up with demand). shock will lead to cardiac arrest and death
PE distrupts ____
blood flow to a region of the lungs. this causes:
Bronchoconstriction due to Alveolar hypocarbia
Shunting with risk of infection of lung tissue
↑ pulmonary vascular resistance
↑ RV workload
Alveolar hypocarbia causes what to happen with the lungs?
low CO2 in alveolar = constriction in lungs
where do emboli originate
DVTs primarily LE but sometimes from UE
Virchow Triad for PE
Venous stasis
Vascular endothelium injury
Hypercoagulability
risk factor for PE
conditions of decreased venous return - Immobility!!
most common symptom of PE
sudden onset of unexplained dyspnea but other s/s can be subtle they include: anxiety, tachypnea, tachycardia, Change in LOC secondary to hypoxemia, feeling of impending doom, hypotension, murmur
labs for pulmonary embolism
ABGs - oxygenation
D-Dimer - clotting in the body
BNP - cardiac ventricular stretch
troponin - how big it is
diagnostics for PE
spiral CT unless allergic to IV contrast them V/Q scan. also 12 lead ECG, echocardiogram
potential complications post PE
pulmonary infarction due to insufficient blood flow or
pulmonary HTN due to chronic PE disease or chronic thromboses
care for PE
prevent growth of thrombi, optimize oxygenation and ventilations with O2 therapy and turn cough deep breath, monitor for bleeding due to anticoagulants, pain relief
sign of DVT
Deep calf pain, tenderness, warmth, or redness, unilateral edema
Massive PE
Acute PE w/ sustained SPB <90 for greater than 15 mins
Need for inotropes (no other reason)
Signs of shock
10% of these patients die within the first hour
Submassive PE
Acute PE w/ RV dysfunction
Myocardial necrosis present
Acute PE:
Signs and symptoms immediately after obstruction
Thrombolytics
Fibrolytics (AKA Alteplase or tPA)
Massive PE treatment
Throbolytics/Fibrolytics: recommended for pts with a low to moderate risk of bleeding. Avoid patients at high risk to bleed: hx or current intracranial hemorrhage, cerebrovascular disease, neoplasm, suspected aortic dissection, w/in 3 months of ischemic cerebral vascular accident
Submassive PE treatment
Thrombolytics considered on a case by case basis
Vitamin-K antagonist
warfarin - is main therapy with PE bridged w/ parenteral anti-coagulants but needs frequent monitoring of INR
Direct oral anticoagulants (DOACs)
can be used to treat PE - Examples: Xarelto, Pradaxa, Eliquist. more predictable and no lab monitoring
low molecular weight heparin example
enoxaparin sodium - no lab needed
warfarin INR goal
2-3
when pts are receiving anticoagulation therapy, priority is to
assess for bleeding and all associated signs and symptoms of a potential bleed
Heparin lab
PTT (goal is 50-90)
bridge therapy
Initial treatment begins with heparin or LMWH.
Warfarin (least 5 days) or a DOAC (1-2 days) is started and continued with the heparin/LMWH until the designated time frame and then the heparin/LMWH is stopped
Warfarin/DOAC are PO and patients can take these long term at home (at least 3 months post PE)
hyperventilation
blowing off CO2 - vasoconstriction
hypoventilation
keeping CO2 - vasodilation
two types of trauma
blunt force and penetrating
signs and symptoms of crush injury
petechiae in the whites of the eyes, cheeks, and face
pneumothorax
air in the pleural space resulting in partial collapse of lung - pressure goes from negative to positive